313 related articles for article (PubMed ID: 29544677)
1. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
2. Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.
Guo LT; Zhang XU; Kuang W; Xu H; Liu LA; Vilquin JT; Miyagoe-Suzuki Y; Takeda S; Ruegg MA; Wewer UM; Engvall E
Neuromuscul Disord; 2003 Mar; 13(3):207-15. PubMed ID: 12609502
[TBL] [Abstract][Full Text] [Related]
3. Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.
Gawlik KI; Durbeej M
Sci Rep; 2015 Sep; 5():13916. PubMed ID: 26355035
[TBL] [Abstract][Full Text] [Related]
4. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
5. Early skeletal muscle pathology and disease progress in the dy
Gawlik KI; Körner Z; Oliveira BM; Durbeej M
Sci Rep; 2019 Oct; 9(1):14324. PubMed ID: 31586140
[TBL] [Abstract][Full Text] [Related]
6. Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy
Rabie M; Yanay N; Fellig Y; Konikov-Rozenman J; Nevo Y
Clin Neurophysiol; 2019 Oct; 130(10):1988-1994. PubMed ID: 31476705
[TBL] [Abstract][Full Text] [Related]
7. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
[TBL] [Abstract][Full Text] [Related]
8. Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice.
Gawlik K; Miyagoe-Suzuki Y; Ekblom P; Takeda S; Durbeej M
Hum Mol Genet; 2004 Aug; 13(16):1775-84. PubMed ID: 15213105
[TBL] [Abstract][Full Text] [Related]
9. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
[TBL] [Abstract][Full Text] [Related]
10. Dual transgene amelioration of Lama2-null muscular dystrophy.
McKee KK; Yurchenco PD
Matrix Biol; 2023 Apr; 118():1-15. PubMed ID: 36878377
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study.
Fontes-Oliveira CC; M Soares Oliveira B; Körner Z; M Harandi V; Durbeej M
Sci Rep; 2018 Nov; 8(1):16302. PubMed ID: 30389963
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.
Gawlik KI; Akerlund M; Carmignac V; Elamaa H; Durbeej M
PLoS One; 2010 Jul; 5(7):e11549. PubMed ID: 20657839
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
14. Antioxidants Reduce Muscular Dystrophy in the
Harandi VM; Oliveira BMS; Allamand V; Friberg A; Fontes-Oliveira CC; Durbeej M
Antioxidants (Basel); 2020 Mar; 9(3):. PubMed ID: 32197453
[TBL] [Abstract][Full Text] [Related]
15. Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.
Gawlik KI; Holmberg J; Svensson M; Einerborg M; Oliveira BM; Deierborg T; Durbeej M
Sci Rep; 2017 Mar; 7():44059. PubMed ID: 28281577
[TBL] [Abstract][Full Text] [Related]
16. Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.
Gawlik KI; Mayer U; Blomberg K; Sonnenberg A; Ekblom P; Durbeej M
FEBS Lett; 2006 Mar; 580(7):1759-65. PubMed ID: 16504180
[TBL] [Abstract][Full Text] [Related]
17. A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD.
Gawlik KI; Durbeej M
Front Mol Neurosci; 2020; 13():59. PubMed ID: 32457577
[TBL] [Abstract][Full Text] [Related]
18. Merosin and congenital muscular dystrophy.
Miyagoe-Suzuki Y; Nakagawa M; Takeda S
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
[TBL] [Abstract][Full Text] [Related]
19. The laminin alpha2 expressed by dystrophic dy(2J) mice is defective in its ability to form polymers.
Colognato H; Yurchenco PD
Curr Biol; 1999 Nov; 9(22):1327-30. PubMed ID: 10574769
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
